Discover how peptones enhance mAb and AAV production—boosting cell growth, improving yield, and increasing consistency in gene therapy workflows.

Even though the market for the top-tier restricted free agents has yet to materialize, Jonathan Kuminga is still seeking a lucrative contract from either the Golden State Warriors or another club.

Tempus AI, Inc. (NASDAQ:TEM) is one of the top 10 healthcare AI stocks to buy according to hedge funds. On June 30, 2025, Guggenheim analyst Subbu Nambi reaffirmed a “Buy” rating on Tempus AI ...

On July 10, 2025, Tempus AI, Inc. (NASDAQ:TEM) announced an update about its strategic partnership with Personalis.

Nicholas Robertson of the Toronto Maple Leafs was one of 11 players who filed for salary arbitration July 5, according to the NHL Players' Association. The 23-year-old forward had 22 points (15 ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.

The 34-year-old has one season remaining on the four-year, $16 million contract ($4 million AAV) he signed with the Blues on July 13, 2022.

Colorado Avalanche general manager Chris MacFarland can right some wrongs with Martin Nečas. MacFarland incited rage among the fanbase after shipping superstar winger Mikko Rantanen to the ...

Our updated list features details on every player signed beginning on June 30.

Following a tumultuous week for Sarepta Therapeutics, the biotech has confirmed that a third patient has died after receiving one of the company’s gene therapies. While the previous two deaths ...

The Anaheim Ducks have their goaltender of the future: Lukáš Dostál. According to multiple sources, the contract is for five years and carries an annual average value of $6.5 million. Dostál ...

After a flurry of activity, it's slim pickings for Tuesday's opening of free agency. Who could your team land? Here are our top targets.